Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer

Discoidin domain receptor 2 (DDR2) is arising as a promising therapeutic target in breast carcinoma (BC). The ability of DDR2 to bind to collagen promotes protumoral responses in cancer cells that influence the tumor microenvironment (TME). Nonetheless, the interrelation between DDR2 expression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Romayor, Irene, García-Vaquero, Marina Luque, Márquez, Joana, Arteta, Beatriz, Barceló, Ramón, Benedicto, Aitor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187291/
https://www.ncbi.nlm.nih.gov/pubmed/35711892
http://dx.doi.org/10.1155/2022/5169405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187291/
https://www.ncbi.nlm.nih.gov/pubmed/35711892
http://dx.doi.org/10.1155/2022/5169405

Ejemplares similares